ArticleBlood2022

Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs.

Jonas S Jutzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.